How microRNAs influence both hereditary and inflammatory-mediated colon cancers
Authors:
- 1 September 2013
- journal article
- review article
- Published by Elsevier in Cancer Genetics
- Vol. 206 (9-10) , 309-316
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancerBritish Journal of Cancer, 2012
- A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulationOncogene, 2011
- Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformationInflammatory Bowel Diseases, 2011
- Identification of microRNAs associated with ileal and colonic Crohnʼs disease†Inflammatory Bowel Diseases, 2010
- MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cellsExperimental Cell Research, 2009
- The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancersGenes, Chromosomes and Cancer, 2008
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- MicroRNA expression profiles classify human cancersNature, 2005
- MicroRNA biogenesis: coordinated cropping and dicingNature Reviews Molecular Cell Biology, 2005
- Cancer genes and the pathways they controlNature Medicine, 2004